289 related articles for article (PubMed ID: 25651905)
21. Biotherapy and treatment of adult primary chronic rhinosinusitis with nasal polyps: Cellular and molecular bases.
Bartier S; Coste A; Béquignon E
Eur Ann Otorhinolaryngol Head Neck Dis; 2021 Oct; 138(5):355-362. PubMed ID: 33358657
[TBL] [Abstract][Full Text] [Related]
22. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis.
Geng B; Dilley M; Anterasian C
Curr Allergy Asthma Rep; 2021 Jun; 21(6):36. PubMed ID: 34110505
[TBL] [Abstract][Full Text] [Related]
23. Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: A real-world study.
Bajpai S; Marino MJ; Rank MA; Donaldson AM; O'Brien EK; Lal D
Int Forum Allergy Rhinol; 2021 Aug; 11(8):1152-1161. PubMed ID: 33527730
[TBL] [Abstract][Full Text] [Related]
24. Diverse Endotypes of Chronic Rhinosinusitis and Clinical Implications.
Xie X; Xuan L; Zhao Y; Wang X; Zhang L
Clin Rev Allergy Immunol; 2023 Dec; 65(3):420-432. PubMed ID: 38175322
[TBL] [Abstract][Full Text] [Related]
25. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis.
Nagarkar DR; Poposki JA; Tan BK; Comeau MR; Peters AT; Hulse KE; Suh LA; Norton J; Harris KE; Grammer LC; Chandra RK; Conley DB; Kern RC; Schleimer RP; Kato A
J Allergy Clin Immunol; 2013 Sep; 132(3):593-600.e12. PubMed ID: 23688414
[TBL] [Abstract][Full Text] [Related]
26. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management.
Bachert C; Han JK; Wagenmann M; Hosemann W; Lee SE; Backer V; Mullol J; Gevaert P; Klimek L; Prokopakis E; Knill A; Cavaliere C; Hopkins C; Hellings P
J Allergy Clin Immunol; 2021 Jan; 147(1):29-36. PubMed ID: 33227318
[TBL] [Abstract][Full Text] [Related]
27. Adverse events of biological therapy in chronic rhinosinusitis with nasal polyps: A systematic review.
Aldajani A; Alroqi A; Alromaih S; Aloulah MO; Alsaleh S
Am J Otolaryngol; 2022; 43(6):103615. PubMed ID: 36057193
[TBL] [Abstract][Full Text] [Related]
28. Nasal polyps and rhinosinusitis.
Kwah JH; Peters AT
Allergy Asthma Proc; 2019 Nov; 40(6):380-384. PubMed ID: 31690375
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis.
Cai S; Xu S; Lou H; Zhang L
J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1876-1886.e7. PubMed ID: 35272073
[TBL] [Abstract][Full Text] [Related]
30. [Management of chronic rhinosinusitis].
Wang CS; Zhang L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jul; 30(14):1175-1178. PubMed ID: 29798452
[TBL] [Abstract][Full Text] [Related]
31. Current Evidence for Biologic Therapy in Chronic Rhinosinusitis with Nasal Polyposis.
Ramaswamy US; Melder K; Patel VA; Lee SE
Otolaryngol Clin North Am; 2021 Aug; 54(4):689-699. PubMed ID: 34215357
[No Abstract] [Full Text] [Related]
32. Biologics in Chronic Rhinosinusitis: An Update and Thoughts for Future Directions.
Smith KA; Pulsipher A; Gabrielsen DA; Alt JA
Am J Rhinol Allergy; 2018 Sep; 32(5):412-423. PubMed ID: 30021447
[TBL] [Abstract][Full Text] [Related]
33. Advances in the Knowledge of the Underlying Airway Remodeling Mechanisms in Chronic Rhinosinusitis Based on the Endotypes: A Review.
Lee K; Tai J; Lee SH; Kim TH
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477617
[TBL] [Abstract][Full Text] [Related]
34. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
Patel GB; Peters AT
Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
[TBL] [Abstract][Full Text] [Related]
35. Endotypes of Chronic Rhinosinusitis with Nasal Polyps: Pathology and Possible Therapeutic Implications.
Bachert C; Marple B; Hosemann W; Cavaliere C; Wen W; Zhang N
J Allergy Clin Immunol Pract; 2020 May; 8(5):1514-1519. PubMed ID: 32217158
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers.
Tomassen P; Vandeplas G; Van Zele T; Cardell LO; Arebro J; Olze H; Förster-Ruhrmann U; Kowalski ML; Olszewska-Ziąber A; Holtappels G; De Ruyck N; Wang X; Van Drunen C; Mullol J; Hellings P; Hox V; Toskala E; Scadding G; Lund V; Zhang L; Fokkens W; Bachert C
J Allergy Clin Immunol; 2016 May; 137(5):1449-1456.e4. PubMed ID: 26949058
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes.
Cao PP; Wang ZC; Schleimer RP; Liu Z
Ann Allergy Asthma Immunol; 2019 Jan; 122(1):33-40. PubMed ID: 30326322
[TBL] [Abstract][Full Text] [Related]
38. Chronic rhinosinusitis: Endotypes, biomarkers, and treatment response.
Gurrola J; Borish L
J Allergy Clin Immunol; 2017 Dec; 140(6):1499-1508. PubMed ID: 29106996
[TBL] [Abstract][Full Text] [Related]
39. The role of biologics in chronic rhinosinusitis: a systematic review.
Iqbal IZ; Kao SS; Ooi EH
Int Forum Allergy Rhinol; 2020 Feb; 10(2):165-174. PubMed ID: 31869863
[TBL] [Abstract][Full Text] [Related]
40. Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches.
Kato A; Peters AT; Stevens WW; Schleimer RP; Tan BK; Kern RC
Allergy; 2022 Mar; 77(3):812-826. PubMed ID: 34473358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
